Late-life learning and health: challenges, opportunities, and future directions [0.03%]
终生学习与健康：挑战、机遇和未来方向
Adina Zeki Al Hazzouri,Martine Elbejjani,Maya Abi Chahine et al.
Adina Zeki Al Hazzouri et al.
Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France [0.03%]
法国长期护理机构中Beta新冠病毒变异株和BNT162b2疫苗的有效性
Benjamin Lefèvre,Laura Tondeur,Yoann Madec et al.
Benjamin Lefèvre et al.
Computerised cognitive remediation to enhance mobility in older adults: a single-blind, single-centre, randomised trial [0.03%]
计算机认知修复以提高老年人行动能力：单盲、单中心试验
Joe Verghese,Jeannette R Mahoney,Emmeline Ayers et al.
Joe Verghese et al.
Background: Decline in executive functions and related cognitive processes is associated with mobility decline, and these functions might be amenable to cognitive remediation. This study aimed to examine whether a compute...
Randomized Controlled Trial
The lancet. Healthy longevity. 2021 Sep;2(9):e571-e579. DOI:10.1016/s2666-7568(21)00173-2 2021
A timely call to establish an international convention on the rights of older people [0.03%]
及时呼吁建立老年人国际公约的提案
John E Ataguba,David E Bloom,Andrew J Scott
John E Ataguba
[This corrects the article DOI: 10.1016/S2666-7568(21)00088-X.]. © 2021 The Author(s). Published by Elsevier Ltd.
Published Erratum
The lancet. Healthy longevity. 2021 Aug;2(8):e458. DOI:10.1016/S2666-7568(21)00185-9 2021
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study [0.03%]
关于养老院居民和员工接种BNT162b2或ChAdOx1 nCoV-19新冠疫苗单剂量后的体液免疫反应和细胞免疫反应的回顾性研究（VIVALDI）
Gokhan Tut,Tara Lancaster,Maria Krutikov et al.
Gokhan Tut et al.
Background: Residents of long-term care facilities (LTCFs) have been prioritised for COVID-19 vaccination because of the high COVID-19 mortality in this population. Several countries have implemented an extended interval ...
Observational Study
The lancet. Healthy longevity. 2021 Sep;2(9):e544-e553. DOI:10.1016/S2666-7568(21)00168-9 2021
Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older [0.03%]
延长80岁及以上老年人群中Covid-19疫苗接种间隔的时间
Patrick L Iversen,Sina Bavari
Patrick L Iversen
[This corrects the article DOI: 10.1016/S2666-7568(21)00115-X.]. .
Published Erratum
The lancet. Healthy longevity. 2021 Aug;2(8):e458. DOI:10.1016/S2666-7568(21)00171-9 2021
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis [0.03%]
单剂BNT162b2或ChAdOx1 nCoV-19疫苗在老年人中的免疫原性：探索性分析
Helen Parry,Rachel Bruton,Gokhan Tut et al.
Helen Parry et al.
Background: In several countries, extended interval COVID-19 vaccination regimens are now used to accelerate population coverage, but the relative immunogenicity of different vaccines in older people remains uncertain. In...
Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study [0.03%]
美国退伍军人HIV感染与肺动脉高压发生率之间关系的回顾性队列研究
Meredith S Duncan,Charles W Alcorn,Matthew S Freiberg et al.
Meredith S Duncan et al.
Background: Pulmonary hypertension incidence based on echocardiographic estimates of pulmonary artery systolic pressure in people living with HIV remains unstudied. We aimed to determine whether people living with HIV hav...